I am a
Home I AM A Search Login

Papers of the Week


2022 Dec 10


Arch Gynecol Obstet

Assessing the efficacy of magnesium oxide and riboflavin as preventative treatment of migraines in pregnancy.

Authors

Mazza GR, Solorio C, Stek AM, Kalayjian LA, Wilson ML, Gordon BJ
Arch Gynecol Obstet. 2022 Dec 10.
PMID: 36495328.

Abstract

The purpose of this study is to assess the efficacy of magnesium oxide (MgO) alone and, secondarily, MgO plus riboflavin as preventive treatment of migraines in pregnancy. We hypothesize that MgO alone will be effective for the majority of patients and, when clinically indicated, the addition of riboflavin will result in further benefit.